{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:40:48Z","timestamp":1790991648790,"version":"4.1.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,3]]},"abstract":"<jats:p>This special commentary refers to \u2018Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome\u2019 by Keddie et al. (doi:10.1093\/brain\/awaa433).<\/jats:p>","DOI":"10.1093\/brain\/awaa444","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T04:54:14Z","timestamp":1607144054000},"page":"357-360","source":"Crossref","is-referenced-by-count":81,"title":["COVID-19 vaccine and Guillain-Barr\u00e9 syndrome: let\u2019s not leap to associations"],"prefix":"10.1093","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3174-6027","authenticated-orcid":false,"given":"Michael P","family":"Lunn","sequence":"first","affiliation":[{"name":"1 Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK"},{"name":"2 Department of Neuromuscular Disease, Institute of Neurology, University College London, WC1N 3BG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Cornblath","sequence":"additional","affiliation":[{"name":"3 Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C","family":"Jacobs","sequence":"additional","affiliation":[{"name":"4 Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands"},{"name":"5 Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4289-8264","authenticated-orcid":false,"given":"Luis","family":"Querol","sequence":"additional","affiliation":[{"name":"6 Department of Neurology, Hospital de la Santa Creu I Santa Pau, 8025, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"van Doorn","sequence":"additional","affiliation":[{"name":"4 Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Hughes","sequence":"additional","affiliation":[{"name":"1 Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh J","family":"Willison","sequence":"additional","affiliation":[{"name":"7 College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"2021030904285609400_awaa444-B1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S1474-4422(20)30232-5","article-title":"Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study","volume":"19","author":"Brito Ferreira","year":"2020","journal-title":"Lancet Neurol"},{"key":"2021030904285609400_awaa444-B2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10654-019-00596-1","article-title":"Vaccines and the risk of Guillain-Barre syndrome","volume":"35","author":"Chen","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"2021030904285609400_awaa444-B3","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barre syndrome","volume":"141","author":"Doets","year":"2018","journal-title":"Brain"},{"key":"2021030904285609400_awaa444-B4","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2020-324837","article-title":"Guillain-Barre syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions","author":"Filosto","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021030904285609400_awaa444-B5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"key":"2021030904285609400_awaa444-B6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3201\/eid2102.131879","article-title":"Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barre syndrome","volume":"21","author":"Hawken","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2021030904285609400_awaa444-B7","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome","author":"Keddie","year":"2021","journal-title":"Brain"},{"key":"2021030904285609400_awaa444-B8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/014107687907200908","article-title":"Guillain-Barre syndrome: the swine influenza virus vaccine incident in the United States of America, 1976-77: preliminary communication","volume":"72","author":"Langmuir","year":"1979","journal-title":"J R Soc Med"},{"key":"2021030904285609400_awaa444-B9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.aje.a113809","article-title":"An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines","volume":"119","author":"Langmuir","year":"1984","journal-title":"Am J Epidemiol"},{"key":"2021030904285609400_awaa444-B10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barre syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"2021030904285609400_awaa444-B11","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1016\/j.vaccine.2019.08.087","article-title":"Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011-July 2018","volume":"37","author":"McNeil","year":"2019","journal-title":"Vaccine"},{"key":"2021030904285609400_awaa444-B12","doi-asserted-by":"crossref","DOI":"10.17226\/12660","volume-title":"The swine flu affair: decision-making on a slippery disease","author":"Neustadt","year":"1978"},{"key":"2021030904285609400_awaa444-B13","first-page":"jiaa543","article-title":"Guillain-Barre syndrome after high-dose influenza vaccine administration in the United States, 2018-2019 season","author":"Perez-Vilar","year":"2020","journal-title":"J Infect Dis"},{"key":"2021030904285609400_awaa444-B14","first-page":"jiaa544","article-title":"Guillain-Barre syndrome following influenza vaccines affords opportunity to improve vaccine confidence","author":"Salmon","year":"2020","journal-title":"J Infect Dis"},{"key":"2021030904285609400_awaa444-B15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the national influenza immunization program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"2021030904285609400_awaa444-B16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"2021030904285609400_awaa444-B17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awaa444\/34880127\/awaa444.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/144\/2\/357\/36454518\/awaa444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/144\/2\/357\/36454518\/awaa444.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T15:55:33Z","timestamp":1723996533000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/144\/2\/357\/6031904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,25]]},"published-print":{"date-parts":[[2021,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awaa444","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2021,2,1]]}}}